Mucocutaneous lymph node syndrome: a new disease.
[No authors listed]
Br Med J. 1977 Feb 12;1(6058):407. doi: 10.1136/bmj.1.6058.407.
Kawasaki Disease.
Selmek K, Harding M.
Pediatr Rev. 2024 Jul 1;45(7):425-427. doi: 10.1542/pir.2023-006051.
An Update on Kawasaki Disease.
Goel AR, Yalcindag A.
Curr Rheumatol Rep. 2024 Dec 3;27(1):4. doi: 10.1007/s11926-024-01167-4.
Mucocutaneous lymph node syndrome: second alert.
Hussey HH.
JAMA. 1977 May 23;237(21):2326-7. doi: 10.1001/jama.1977.03270480066027.
Mucocutaneous lymph node syndrome (Kawasaki disease).
Riley HD Jr.
J Infect Dis. 1976 Sep;134(3):302-5. doi: 10.1093/infdis/134.3.302.
Kawasaki Disease.
Son MBF, Newburger JW.
Pediatr Rev. 2018 Feb;39(2):78-90. doi: 10.1542/pir.2016-0182.
Kawasaki disease.
Sundel RP.
Rheum Dis Clin North Am. 2015;41(1):63-73, viii. doi: 10.1016/j.rdc.2014.09.010.
Acute febrile mucocutaneous lymph node syndrome.
Yanagihara R, Todd JK.
Am J Dis Child. 1980 Jun;134(6):603-14. doi: 10.1001/archpedi.1980.02130180059017.
Kawasaki disease.
Kawasaki T.
Int J Rheum Dis. 2014 Jun;17(5):597-600. doi: 10.1111/1756-185X.12408.
Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).
Landing BH, Larson EJ.
Am J Cardiovasc Pathol. 1987;1(2):218-29.
